Rubric Capital Management LP 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-31 11:08 am Unchanged | 2023-11-14 | 13D | Heron Therapeutics, Inc. HRTX | Rubric Capital Management LP | 26,713,503 17.700% | 0 (Unchanged) | Filing |
| 2023-07-25 4:13 pm Purchase | 2023-07-21 | 13D | Heron Therapeutics, Inc. HRTX | Rubric Capital Management LP | 26,713,503 19.000% | 14,963,503 (+127.35%) | Filing |
| 2023-02-22 4:24 pm Unchanged | 2023-02-21 | 13D | Heron Therapeutics, Inc. HRTX | Rubric Capital Management LP | 11,750,000 9.900% | 0 (Unchanged) | Filing |
| 2023-02-06 09:00 am Purchase | 2023-01-25 | 13D | Heron Therapeutics, Inc. HRTX | Rubric Capital Management LP | 11,750,000 9.900% | 11,750,000 (New Position) | Filing |